Tumor-associated macrophages as targets for cancer therapy.
Wahl
L M
LM
Kleinman
H K
HK
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D006801:Humans; D006912:Hydroxyquinolines / Q000494:pharmacology*; D007371:Interferon-gamma / Q000378:metabolism; D018664:Interleukin-12 / Q000378:metabolism; D020382:Interleukin-18 / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism*; D017396:Plasminogen Activator Inhibitor 2 / Q000096:biosynthesis / Q000378:metabolism*
D000970:Antineoplastic Agents; D006912:Hydroxyquinolines; D020382:Interleukin-18; D017396:Plasminogen Activator Inhibitor 2; D018664:Interleukin-12; C045282:roquinimex; D007371:Interferon-gamma